pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 3·1 min read
save

Trump administration's new Medicaid work-requirement rules surprise states and patients

Jun 3, 2026·read at STAT ↗RegulatoryNegative

Medicaid leaders and advocates say they are shocked by the Trump administration's latest directives that tighten work‑requirement rules for the program, a shift from the tone of earlier federal statements.

The Centers for Medicare & Medicaid Services issued a nearly 400‑page rule that makes it significantly harder for individuals to qualify for Medicaid and to stay enrolled, according to the article.

Advocates warn the stricter requirements could leave many patients without coverage and create unexpected challenges for state Medicaid programs.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Trump’s Medicaid work requirements have an unwelcome surprise for some states and patients”

read at STAT ↗
684 words · retrieved Jun 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Protara Therapeutics, Inc.7Legend Biotech CorpUltragenyx Pharmaceutical Inc.
drugs
PLUVICTOlutetium Lu 177 vipivotide tetraxetan
topics
OncologyRadioligand TherapyRare Disease

related stories

  • Jun 4Opinion: Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this storySTAT
  • Jun 3STAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeuticsSTAT
  • Jun 3STAT+: HaloMD faces lawsuit alleging No Surprises Act middleman used ‘sham letter,’ misleading dataSTAT
  • Jun 3STAT+: Legend Biotech emerged as a rare market winnerSTAT
  • Sep 23Novartis bets up to $900M for radioligand therapy from China’s BoomRayBioSpace